| Similar Articles |
|---|
 |
Pharmaceutical Executive
September 1, 2013
Jordan Sarver |
Pathology in the Era of Personalized Medicine With their knowledge of molecular genetics, Pathologists are transforming the way healthcare is provided.   |
Pharmaceutical Executive
March 1, 2011
Jerry Coamey |
Engage the Physician! New research shows that gauging the mind of the clinician is crucial to timely uptake of the new diagnostic tools offered by the genomic revolution |
Pharmaceutical Executive
September 1, 2005
Wolfgang Klietmann |
Thought Leader: (Eco)systemic Change The author discusses how various players within the healthcare system interact. |
Pharmaceutical Executive
June 1, 2006
Nancy Dreyer |
Personalized Medicine Meets the Real World A wave of genomic medicines is coming down the pipeline, and they're going to be expensive. Can companies prove they're worth it? Maybe: but the claims payers seek aren't coming from traditional clinical trials. |
Bio-IT World
July 2005
Kevin Davies |
Medicine Gets Personal Touch More genomics-based drugs are moving into development with others, such as new cancer drugs showcasing on the clinical pharmacogenics scene as outlined in the Advances in Genomic Medicine program of a recent world conference. |
BusinessWeek
January 21, 2010
John Carey |
Making Personalized Medicine Pay Medco and other pharmacy benefit managers say future profits depend on matching drugs to patients based on their genes. |
Wired
July 2006
Kevin Kelleher |
Personalize It While Adidas offers customized shoes for your feet, the pharmaceutical industry is moving toward personalizing drugs based on your genes. |
Pharmaceutical Executive
March 1, 2013
Keeling & Paz |
Early Engagement with Medical Laboratories Timely engagement is the key to expanding the use of companion diagnostics. |
Pharmaceutical Executive
October 1, 2008 |
Getting Personal(ized) Stop worrying about shrinking the market for your drug, and start figuring out how the "test and treat" business model works. |
Knowledge@Wharton
August 27, 2003 |
Code Blue: Combating Rising Healthcare Costs Calls for Strong Medicine It's been said many times over that the U.S. healthcare industry is a sick patient in search of a cure. The metaphor is a grim reflection of how the country is coping with an aging population, rising costs and an inefficient healthcare delivery system. |
Bio-IT World
March 2007
Michael A. Greeley |
Can I Get Personal? VC's are back and seem very excited about the broader disease management and personalized medicine investment opportunities. |
Commercial Investment Real Estate
May/Jun 2013
Mauldin & Maddron |
Medical Office Momentum The Affordable Care Act takes some risk out of healthcare property investment. |
Bio-IT World
February 2007
Kevin Davies |
Obama Declares for Personalized Medicine Barack Obama is one of few members of congress who sees the genomics tidal wave and is doing something about it. Obama may be a Democrat, but drug and biotech industries have reason to hope. |
Nursing Management
September 2010
Richard Hader |
The evidence that isn't... Interpreting research When patients seek a healthcare practitioner for services, they believe that the delivered care is based on proven science. But reality is far from patient perception. In fact, most care is still based on anecdote, not evidence. |
The Motley Fool
February 24, 2011
Brian Orelli |
Profit From Personalized Medicine Pfizer's drug works well, but consider these companies instead. |
Bio-IT World
November 14, 2003
Kathy Ordonez |
Targeted Medicine via Molecular Diagnostics Using diagnostics to select and deselect target populations for drug therapy will enable life scientists to make more effective medicines. |
Pharmaceutical Executive
August 1, 2012
Pascheles & Bogan |
The Ultimate Business Model: Planning that Thousand Year Future In an era where success is monitored and measured in microseconds, planning for the long term is increasingly seen as an abstract absurdity. Yet the principles of natural selection, when applied to the pharmaceutical business, suggest that a lasting business model is still possible. |
Wired
September 22, 2008
Katharine Gammon |
Leroy Hood: Look to the Genome to Rebuild Health Care The 69-year-old biotechnologist bases his health care plan on the four Ps -- medicine that is predictive, preventive, personalized, and participatory. |
CRM
August 1, 2009
Lauren McKay |
Healing the Sick Facing regulatory requirements, spiraling costs, and an aging (and ailing) customer base, the healthcare industry looks to CRM to balance a pair of age-old doctrines: First, do no harm - and physician, heal thyself. |
InternetNews
February 6, 2009
David Needle |
IBM's Shot in the Arm for Google Health Tech IBM helps the Google's online health records initiative. But where does privacy fit in? |
Chemistry World
July 2010
Anna Lewcock |
Medicine made to measure Healthcare tailored to suit the genetic makeup of the patient is finally coming to fruition. |
Fast Company
David Lumb |
Sites That Sell Cancer Gene Tests Don't Tell Customers The Whole Story, Study Finds Consumer tests that analyze DNA from tumors in order to help personalize a patient's treatment are in something of a Wild West period. |
Managed Care
May 2001
Michael D. Dalzell |
Powerful Opportunities For Good and Greed Genetic advances could spawn incredible improvements in health care. Given public demand, they also pose what may be unmanageable issues of resource use... |
Managed Care
May 2005
Martin Sipkoff |
Predictive Modeling & Genomics: Marriage of Promise and Risk Integration of predictive modeling and genomic tools means improved technology, enhanced databases, and appropriate legal guidance. |
BusinessWeek
September 5, 2005 |
Putting the FDA Out Front Deputy Commissioner Dr. Janet Woodcock explains how the agency has led the drive for personalized medicine. |
Managed Care
November 2006
Maureen Glabman |
Genetic Testing: Major Opportunity, Major Problems Whether a person is likely to develop diabetes, cancer, schizophrenia, or stroke will be reasonably well predicted, and tests can also determine whether a patient will respond to a given therapy. That's the good part. |
Pharmaceutical Executive
May 1, 2005
Marsha Meyer |
Medical Education: Prevention Education Shifting the nation's healthcare paradigm from treating seniors' ills to preventing them will take the combined support of pharma companies, medical schools, continuing medical education (CME) providers, and clinicians. |
Pharmaceutical Executive
April 1, 2011 |
Bridging the HCP-Patient Gap Here's what's necessary to bridge the gap between the patient revolution and healthcare provider in the 21st century. |
Pharmaceutical Executive
June 1, 2011 |
To Screen or Not to Screen? What do our genetics tell us about our predisposition to certain diseases? What does this mean for pharmaceutical companies? |
Nursing Management
October 2011
Edna Cadmus |
Your role in redesigning healthcare We need to rethink how we provide care and to understand the interconnectedness and the structure of healthcare by looking at it as a whole vs. the sum of its parts. As leaders we need to view the evidence as we rethink healthcare together. |
The Motley Fool
May 21, 2010
Gregory T. Huang |
How Microsoft Will Become a Top Player in Health IT From the mouth of a top leader in the unit. |
Bio-IT World
November 14, 2003
Jeff Augen |
Making Information-Based Medicine Work A confluence of scientific discovery and high-throughput technology has made information-based medicine possible -- and imperative. |
BusinessWeek
September 5, 2005
Capell & Arndt |
Drugs Get Smart Future medicines will more effectively target what ails you by tailoring treatment to your specific genetic profile. Personalized medicine will also help prevent another Vioxx. |
Bio-IT World
June 2006
Kevin Davies |
The Data Deluge: Deal or No Deal? Far from decrying the data glut, researchers should embrace the complexity of genomic and other sources of data, particularly for its predictive properties in the field of personalized medicine. |
Bio-IT World
March 17, 2004 |
IBM: Pedal to the Metal in Healthcare IBM now melds healthcare, life sciences, and IT. |
Job Journal
January 18, 2009 |
Career Snapshot: Registered Nurse Registered nurses have a wealth of career opportunities to choose from. |
HBS Working Knowledge
July 12, 2006
Roger Thompson |
Competition the Cure for Healthcare Michael Porter is considered by many the world's foremost authority on competition and strategy. So when he discusses the need for fundamental reform in the way the United States delivers healthcare, people listen. |
Pharmaceutical Executive
November 1, 2011
Elizabeth O. Coulton |
Clinical Trial Issues Not Just Black and White The selection of clinical trial participants must meld with the changing demographics of America if industry is to improve medicines that work for patients. |
Pharmaceutical Executive
January 1, 2012 |
Here's to a Happier New Year? A turbulent year is ahead for European pharma, while EFPIA's Director General begins to rethink its approach to new science. |
Pharmaceutical Executive
July 30, 2007
Peter Pitts |
Opinion: Fewer Cents, More Sense Our healthcare system may be broken, but playing the blame game is not going to fix it. Remember that disease - not Big Pharma - is the enemy. |
Insurance & Technology
August 4, 2009
John Reynolds |
Electronic Health Records: A Place to Start, Not a Destination End-game electronic health record solutions need to focus on integrating individuals' health with wealth and making it personal and actionable in a consumer-directed healthcare world. |
CIO
August 27, 2013
Brian Eastwood |
Healthcare IT Struggles to Keep Up With Mobile Health Demands While healthcare struggles with unique legal and regulatory impediments that other fields don't face, it's also poised to gain much more from what some call a 'mobile revolution.' |
Managed Care
April 2001 |
U.S. Health Care 'Substandard,' Says IOM Report Managed care -- a whipping boy for all that is wrong with health care in the U.S. -- is not to blame for a badly fragmented system that provides incentives to treat acute episodes and not manage chronic illness, according to the Institute of Medicine's landmark report... |
Pharmaceutical Executive
April 1, 2007 |
Thoughtleader: Melissa Brown, Center for Value-Based Medicine Here, co-author Melissa Brown discusses her book Evidence-Based to Value-Based Medicine and what's driving the move toward value-based medicine, how it will affect pharma, and why executives should embrace it. |
The Motley Fool
August 24, 2007
Brian Orelli |
Take Your Medicine; Earn Your Profits Personalized medicine offers investment ideas. Let's take a look at what this new catchphrase in the medical community actually means, and how investors can benefit from it. |
Insurance & Technology
August 18, 2010
Nathan Golia |
Insurers Take Lead in EHR Implementation With guidelines for meaningful use of electronic health records established, health carriers expect IT improvements on the provider side to lower healthcare costs by reducing care redundancies and readmissions. |
Pharmaceutical Executive
May 1, 2007
Steve Singer |
Medical Education: Community of Change Continuing medical education professionals need not reinvent the wheel to accomplish more. But we do have to better align our approaches to the way in which healthcare is actually delivered. |
Managed Care
February 2002
Alan M. Muney |
Evidence-Based Medicine Needs To Be Promoted More Vigorously This means using a carrot-and-stick approach with physicians. Those who respect the evidence should be rewarded; others should face penalties... |
Pharmaceutical Executive
June 1, 2011 |
Are You Ready for the New China? The ability to act as a good corporate citizen and assert a useful role in national industrial policy on health is going to be essential to success in the new China. |
InternetNews
February 18, 2011
Stuart J. Johnston |
IBM's Watson Goes from Jeopardy to Medicine After its supercomputer flattened two human challengers at Jeopardy, IBM announced a collaboration with a leading voice technology firm to teach the computer bedside manners. |
